Response and Resistance to BCR-ABL1-Targeted Therapies
Theodore P. Braun, Christopher A. Eide, Brian Druker
Topics & Concepts
ImatinibTyrosine-kinase inhibitorMedicineTyrosine kinaseMyeloid leukemiaImatinib mesylateCancer researchDasatinibPonatinibDrug resistanceABLDiscontinuationTargeted therapyOncologyChronic myelogenous leukemiaPharmacologyCancerLeukemiaImmunologyInternal medicineBiologyGeneticsReceptorChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchEosinophilic Disorders and Syndromes